T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$1.66B | |
| 2 | +$1.39B | |
| 3 | +$1.38B | |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| 1 | +$4.2B | |
| 2 | +$3.24B | |
| 3 | +$2.75B | |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| 1 | Technology | 35.67% |
| 2 | Financials | 11.77% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Ingredion
INGR
$7.06B
| $15.1M | ﹤0.01% |
136,564
+7,085
|
|
||
1127
Petrobras Class A
PBR.A
$110B
| $15M | ﹤0.01% |
1,331,789
|
|
||
1128
AES
AES
$10.1B
| $15M | ﹤0.01% |
1,046,159
+3,418
|
|
||
1129
EchoStar
SATS
$31.6B
| $15M | ﹤0.01% |
137,869
+7,337
|
|
||
1130
Norwegian Cruise Line
NCLH
$9.1B
| $15M | ﹤0.01% |
669,992
+11,169
|
|
||
|
SEI
1131
Solaris Energy Infrastructure
SEI
$2.56B
| $14.8M | ﹤0.01% |
321,448
-406,925
|
|
||
1132
Advanced Energy
AEIS
$11.3B
| $14.7M | ﹤0.01% |
70,145
+35,641
|
|
||
1133
Mine Safety
MSA
$7.05B
| $14.7M | ﹤0.01% |
91,480
-301,744
|
|
||
1134
Moderna
MRNA
$21.2B
| $14.6M | ﹤0.01% |
494,013
+11,148
|
|
||
1135
Baxter International
BAX
$9.22B
| $14.6M | ﹤0.01% |
761,411
-12,690,881
|
|
||
1136
Charles River Laboratories
CRL
$8B
| $14.5M | ﹤0.01% |
72,856
|
|
||
1137
BlackLine
BL
$2.22B
| $14.5M | ﹤0.01% |
262,811
+1,588
|
|
||
1138
CarGurus
CARG
$2.99B
| $14.4M | ﹤0.01% |
376,648
-1,254
|
|
||
|
NBIS
1139
Nebius Group N.V.
NBIS
$27.6B
| $14.4M | ﹤0.01% |
172,564
+102,986
|
|
||
1140
UroGen Pharma
URGN
$902M
| $14.4M | ﹤0.01% |
616,606
+259,991
|
|
||
1141
iShares Core MSCI EAFE ETF
IEFA
$169B
| $14.4M | ﹤0.01% |
160,781
-4,818
|
|
||
1142
WESCO International
WCC
$12.8B
| $14.3M | ﹤0.01% |
58,501
+4,866
|
|
||
1143
Simply Good Foods
SMPL
$1.38B
| $14.2M | ﹤0.01% |
705,176
+10,291
|
|
||
1144
Ryan Specialty Holdings
RYAN
$4.84B
| $14.1M | ﹤0.01% |
273,113
+8,166
|
|
||
1145
A.O. Smith
AOS
$9.36B
| $14.1M | ﹤0.01% |
210,688
-17,809
|
|
||
|
ETOR
1146
eToro Group
ETOR
$2.45B
| $14.1M | ﹤0.01% |
399,937
+291,985
|
|
||
1147
Kinsale Capital Group
KNSL
$8.44B
| $14M | ﹤0.01% |
35,910
+705
|
|
||
1148
Relay Therapeutics
RLAY
$1.84B
| $13.9M | ﹤0.01% |
1,645,403
+507,722
|
|
||
1149
Tetra Tech
TTEK
$8.93B
| $13.9M | ﹤0.01% |
413,523
+18,676
|
|
||
1150
Glaukos
GKOS
$5.73B
| $13.8M | ﹤0.01% |
122,169
+5,263
|
|